Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott C Kogan

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Cancer Cell|December 30, 2008
Curing APL: differentiation or destruction?Scott C Kogan
Blood|March 18, 2021
PML-RARα: changing myeloid networksScott C Kogan
Science (New York, N.Y.)|April 10, 2010
Medicine. Poisonous contactsScott C Kogan
Haematologica|July 2, 2026
The risks of delay?Scott C Kogan
International Journal of Laboratory Hematology|September 9, 2018
Dilute Russell viper venom time interpretation and clinical correlation: A two-year retrospective institutional reviewCyril Jacquot, Geoffrey D Wool, Scott C Kogan
Leukemia Research|December 23, 2006
Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic miceBrian D Lee, Sabina Sevcikova, Scott C Kogan
The Journal of Biological Chemistry|February 28, 2006
Increased CCAAT enhancer-binding protein epsilon (C/EBPepsilon) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropeniaDazhong Zhuang, Yaling Qiu, Scott C Kogan, et al.
Journal of the American College of Cardiology|October 15, 2021
Preventing Bleeding With Direct-Acting Oral AnticoagulantsJanice B Schwartz, Scott C Kogan, Margaret C Fang
Blood|April 4, 2002
Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemiaMichelle M Le Beau, Sheila Bitts, Elizabeth M Davis, et al.
Haematologica|June 22, 2023
Impact of pinworm infection on the development of murine B-cell leukemia/lymphoma in the presence and absence of <i>ETV6::RUNX1</i>Briana A Fitch, Jamilla Situ, Joseph L Wiemels, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Cancer Cell|December 30, 2008
Curing APL: differentiation or destruction?Scott C Kogan
Blood|March 18, 2021
PML-RARα: changing myeloid networksScott C Kogan
Science (New York, N.Y.)|April 10, 2010
Medicine. Poisonous contactsScott C Kogan
Haematologica|July 2, 2026
The risks of delay?Scott C Kogan
International Journal of Laboratory Hematology|September 9, 2018
Dilute Russell viper venom time interpretation and clinical correlation: A two-year retrospective institutional reviewCyril Jacquot, Geoffrey D Wool, Scott C Kogan
Leukemia Research|December 23, 2006
Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic miceBrian D Lee, Sabina Sevcikova, Scott C Kogan
The Journal of Biological Chemistry|February 28, 2006
Increased CCAAT enhancer-binding protein epsilon (C/EBPepsilon) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropeniaDazhong Zhuang, Yaling Qiu, Scott C Kogan, et al.
Journal of the American College of Cardiology|October 15, 2021
Preventing Bleeding With Direct-Acting Oral AnticoagulantsJanice B Schwartz, Scott C Kogan, Margaret C Fang
Blood|April 4, 2002
Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemiaMichelle M Le Beau, Sheila Bitts, Elizabeth M Davis, et al.
Haematologica|June 22, 2023
Impact of pinworm infection on the development of murine B-cell leukemia/lymphoma in the presence and absence of <i>ETV6::RUNX1</i>Briana A Fitch, Jamilla Situ, Joseph L Wiemels, et al.
Pageof 10